Sixth Street-backed Caris Life valued at $7.7 billion in strong...
By Pritam Biswas and Niket Nishant (Reuters) -Caris Life Sciences’ shares jumped nearly 29% in their Nasdaq debut on Wednesday, fetching the cancer diagnostic firm a valuation of $7.66 billion...